Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 1011 · · 10 pages · English
Summary by 6ix AI
It reports on the movements in authorized and registered share capital, as well as issued shares and treasury shares. The document confirms compliance with public float requirements and includes details of share allotments and issuances. The filing serves to inform the Hong Kong Exchanges and Clearing Limited about the company's securities activities during the specified month.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
China NT Pharma Group Co., Ltd. on 6ix
Earlier from China NT Pharma
- Notification Letter and Request Form to Non-Registered Holder
- Notification Letter and Reply Form to Registered Shareholder
- 2026 Interim Report
- Voluntary announcement in relation to the application for compulsory enforcement by a wholly-owned subsidiary in respect of the shareholders' right to information of beijing kangchen biological technology co., limited
- Inside information announcement arbitration award
Later from China NT Pharma
- Appointment of auditor and notice of extraordinary general meeting
- Notice of extraordinary general meeting
- Form of proxy for use at extraordinary general meeting
- Supplemental announcement supplemental information in relation to the annual report for the year ended 31 December 2025
Follow China NT Pharma into a list and get an email when it puts out news.
Follow China NT Pharma